Indeed, IL-7 administration mainly in HIV-infected or immunosuppressed patients was generally well tolerated [22, 23, 25, 27, 28, 45], with a single report of a patient developing systemic lupus erythematosus after 3 doses of IL-7 [45]. This evidence concerns the gene IL7 and systemic lupus erythematosus.